Clinuvel Pharmaceuticals Ltd
CUVL
$5.27
▲
+0.32
(+6.57%)
at close
4
Visible periods
5
Metrics
Peer-ranked
Benchmarks
Price Chart
72
Health
Good
Bullish
auto_awesome
Analytical Summary
Clinuvel Pharmaceuticals Ltd shows strong fundamentals with top-quartile Profit Margin (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
1.4x
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Nov 5, 2026.
trending_up
Bullish Indicators
- Operating Margin (%)Operating Margin (%) is in the top quartile
- Profit Margin (%)Profit Margin (%) is in the top quartile
warning
Bearish Risks
- No bearish risks detected.
Health Breakdown
Profitability ↓
89
Returns ↓
67
Cash Quality ↓
38
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is the balance sheet risky?
1 metrics
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare CUVL against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CUVL against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for CUVL
Bullish
2
Operating Margin (%)
43.4%
Operating Margin (%) is in the top quartile
Profit Margin (%)
36.0%
Profit Margin (%) is in the top quartile
Bearish
0
No bearish signals detected
Percentile Rankings
How CUVL compares to all companies
Return on Common Equity (%)
12.3%
Top 50%
Peers: Top 100%
Profit Margin (%)
36.0%
Top 5%
Peers: Top 100%
Operating Margin (%)
43.4%
Top 5%
Peers: Top 100%
Compare CUVL with peers
Stack CUVL against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 4 days ago 4 years · 4 quarters